MSD - We believe the most important condition is the human one.

MSD New Zealand

From developing new therapies that treat and prevent disease to helping people in need, we're committed to improving health and well-being.

MSD Animal Health
We bring our customers new products and new ideas so that their own businesses can flourish. Click here to go to our Animal Health Website

MSD Products

Our core business is the discovery and development of medicines for diseases and conditions that impact millions of people.
We are currently updating our website; for information about our products check out the New Zealand Medsafe website.

Careers @ MSD
At MSD, we seek to discover and champion the latest, most promising advancements against the world’s greatest health challenges. To accomplish this, we are willing to invest in solutions that take us in directions we’ve never explored before. Because we’re on a relentless quest for cures. And we’ll be known differently in our industry because of it. How will YOU invent the future?

Website in progress

Thank you for visiting MSD New Zealand ltd. We are refreshing our website to give you a better experience however it is taking us sometime.
If you need to get in touch: For MSD Medical Information or to report product complaints (including adverse events) Tel: 0800 500 673
To contact us electronically, please email us at DPOC.australia@merck.com. Please note, if your enquiry relates to a MSD medicine, please contact our Medical Information number on 0800 500 673.

Forward-Looking Statement

Forward-Looking Statement of MSD & Co., Inc., Kenilworth, NJ, USA

This website of MSD & Co., Inc., Kenilworth, NJ, USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include, but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and healthcare legislation in the United States and internationally; global trends toward healthcare cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2015 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).

No Duty to Update

The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.